RxDoctor Payments Data

Srikanth Divi, MD

Orthopaedic Trauma · Chicago, ILNPI 1518305457

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Kuros Biosciences USA, Inc at 46.3% of the total.

$54,431in general payments, 2019–2025

Across 182 payments — averaging $299.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kuros Biosciences USA, Inc$25K
  • Alphatec Spine, Inc$16K
  • Stryker$4K
  • Medtronic$3K
  • Collagen Matrix, Inc$3K
  • Johnson & Johnson$511
  • plus $3K from 12 others

What the payments were for

  • Consulting fees$21,05839%
  • Speaking & faculty fees$5001%
  • Travel & lodging$20,43938%
  • Food & beverage$11,41421%
  • Education$7721%
  • Entertainment$2480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Illinoisto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$261,156
Medicare patients
324
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin170$1,940
Mupirocin70$427
Cyclobenzaprine Hcl30$274
Celecoxib15$212
Methylprednisolone27$153
Tramadol Hcl11$31

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →